Editas Medicine

NASDAQ
EDITAS
Stock
Yield per half year: 0%
Dividend yield: 0%
Sector: Healthcare

Reporting Editas Medicine

Reports

IFRS
Reporting Annual
2019 2020 2021 2022 2023
Financial report link link link link link


Capitalization

IFRS
Reporting Annual
2019 2020 2021 2022 2023 LTM Average for 5 years CAGR 5
Capitalization, bln $
1.48 4.11 1.8 0.609 0.77 0.579 1.75 -12.25
Revenue, bln $
0.0205 0.0907 0.0255 0.0197 0.0781 0.067 0.0469 30.67
Net profit, bln $
-0.1235 -0.1094 -0.1851 -0.2044 -0.1532 -0.1935 -0.1551 4.40
EV, bln $
1.05 3.62 1.2 0.216 0.483 0.339 1.31 -14.38
EBITDA, bln $
-0.1411 -0.1348 -0.1931 -0.226 -0.1631 -0.2036 -0.1716 2.94
OIBDA $
-0.1585 -0.1602 -0.2011 -0.2476 -0.1791 -0.1893 2.47
Book value, bln $
0.262 0.394 0.554 0.361 0.349 0.232 0.3840 5.90
FCF, bln $
-0.0468 -0.187 -0.1718 -0.1815 -0.1369 -0.1715 -0.1448 23.95
Operating Cash Flow, bln $
-0.0407 -0.1798 -0.1638 -0.1773 -0.1322 -0.1646 -0.1388 26.57
Operating profit, bln $
-0.1409 -0.1348 -0.1931 -0.226 -0.1692 -0.2079 -0.1728 3.73
Operating expenses, bln $
0.1615 0.2256 0.2187 0.2457 0.2412 0.2758 0.2185 8.35
CAPEX, bln $
0.0062 0.0072 0.008 0.0041 0.0047 0.0069 0.0060 -5.39


Balance sheet

IFRS
Reporting Annual
2019 2020 2021 2022 2023 LTM Average for 5 years CAGR 5
Cash, bln $
0.4571 0.5118 0.6199 0.4374 0.3231 0.2791 0.4699 -6.70
Net assets, bln $
0.2624 0.3936 0.5536 0.3607 0.3491 0.232 0.3839 5.88
Assets, bln $
0.5089 0.5726 0.6775 0.5143 0.4992 0.3848 0.5545 -0.38
Net debt, bln $
-0.4281 -0.4856 -0.5935 -0.3934 -0.2866 -0.2404 -0.4374 -7.71
Debt, bln $
0.0291 0.0261 0.0264 0.0439 0.0365 0.0387 0.0324 4.64
Cost of production, bln $
0.0969 0.158 0.0051 0.0063 0.0061 0.0058 0.0545 -42.48


Efficiency

IFRS
Reporting Annual Quarterly
2019 2020 2021 2022 2023 2024 2025 LTM Industry average Average for 5 years CAGR 5
ROE, % -47.14 -27.77 -33.41 -56.62 -43.9 60.35 -41.7680 -1.41
ROA, % -24.27 -19.11 -27.32 -39.74 -30.69 6.69 -28.2260 4.81
ROS, % -602.44 -120.62 -725.88 -1037.56 -196.16 -288.81 -288.81 -288.81 11.54 -507.4440 -16.83
ROCE, % 0 0 10.81
EBIT margin 0 0 16.52
EBITDA margin -688.29 -148.62 -757.25 -1147.21 -208.83 -303.88 -303.88 23.24 -513.1580 15.38
Net margin -602.44 -120.62 -725.88 -1037.56 -196.16 11.54 -536.5320 -20.10
Operational efficiency, % -687.32 -148.62 -757.25 -1147.21 -216.65 -310.3 -310.3 -310.3 15.28 -548.3420 -16.34
FCF yield, % -3.16 -4.55 -9.57 -29.8 -17.78 3.01 -12.9720 41.27


Coefficients

IFRS
Reporting Annual Quarterly
2019 2020 2021 2022 2023 2024 2025 LTM Industry average Average for 5 years CAGR 5
P/E
-11.98 -37.56 -9.7 -2.98 -5.03 12.11 -13.4500 -15.93
P/BV
5.65 10.43 3.24 1.69 2.21 35.24 4.64 -17.12
P/S
72.2 45.3 70.39 30.91 9.86 8.72 45.73 -32.85
P/FCF
-31.62 -21.97 -10.45 -3.36 -5.62 -3.38 -3.38 -3.38 -120.27 -5.2380 -20.21
E/P
-0.0834 -0.0266 -0.1031 -0.3356 -0.199 -0.3342 -0.3342 -0.3342 0.02 -0.2612 26.52
EV/EBIT
0 0 0 57.55
EV/EBITDA
-7.46 -26.88 -6.22 -0.9558 -2.96 25.45 -8.8952 -16.88
EV/S
51.32 39.94 47.14 10.96 6.18 5.06 5.06 5.06 9.01 14.88 -36.00
EV/FCF
-22.48 -19.37 -7 -1.19 -3.53 -1.98 -1.98 -1.98 -57.66 -3.1360 -22.32
Debt/EBITDA
-0.2062 -0.1936 -0.1367 -0.1942 -0.2238 -0.1901 -0.1901 -0.1901 1.25 -0.1870 6.82
Netdebt/Ebitda
3.03 3.6 3.07 1.74 1.76 1.18 1.18 1.18 0.24 1.79 -17.41
Debt/Ratio
0.0572 0.0456 0.039 0.0854 0.0731 0.1006 0.1006 0.1006 0.23 0.0797 20.87
Debt/Equity
0.1111 0.0662 0.0477 0.1216 0.1046 0.1668 0.1668 0.1668 5.91 0.1215 28.45
Debt/Net Income
-0.2356 -0.2386 -0.1426 -0.2148 -0.2383 -0.2 -0.2 -0.2 7.88 -0.1991 7.00
PEG
0 0 -117.55
Beta
0 0 0 0 0.36
Altman Index
1.91 7.24 1.33 -1.1 -0.2313 -1.05 -1.05 -1.05 15.06 -0.4203 -195.38


Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

Subscribe

Other

IFRS
Reporting Annual
2019 2020 2021 2022 2023 LTM CAGR 5
R&D, bln
0.0969 0.158 0.1425 0.175 0.1716 0.1736 12.11
CAPEX/Revenue, %
30.1 7.89 31.29 20.91 6.04 -27.47